Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B

Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B

A male hepatitis B virus (HBV) carrier in his 40s under hemodialysis treatment exhibited chronic hepatitis (alanine aminotransferase: 41 IU/L, HBV-DNA: >9.1 log copies/mL). Following discontinuation of the initial treatment with pegylated interferon-α-2a at 24 weeks due to adverse effects,...

Full description

Bibliographic Details
Main Authors: Daiki Aomura, Naoki Tachibana, Michiharu Komatsu, Masakazu Kobayashi
Format: Article
Language:English
Published: Karger Publishers 2020-10-01
Series:Case Reports in Nephrology and Dialysis
Subjects:
chronic hepatitis b
end-stage renal disease
hemodialysis
nucleoside analogue
tenofovirdisoproxil fumarate
Online Access:https://www.karger.com/Article/FullText/508806

Internet

https://www.karger.com/Article/FullText/508806

Similar Items